The NEOSETAC project, which focuses on demonstrating the therapeutic potential of a novel Selenium-based therapy for managing breast cancer, will be interested in a recent article published in Insights into Regional Development. Titled “The Karolinska Institute innovation ecosystem for cancer startups: lessons learned and best practices,” the article provides valuable insights into the innovation ecosystem developed by the Karolinska Institute

The Karolinska Institute has established a thriving environment for cancer startups, fostering collaboration and knowledge exchange. The article outlines the lessons learned and best practices employed within this ecosystem, which can serve as a valuable resource for the NEOSETAC project in its mission to explore the potential benefits of high selenium exposure in decreasing cancer risk

The NEOSETAC project aims to demonstrate the therapeutic potential of a novel Selenium-based therapy for managing breast cancer. Recent clinical studies have shown that high selenium exposure could decrease cancer risk, particularly high plasma/serum selenium and toenail selenium levels. NEOSETAC will showcase the potential of Selenium-based compounds to target breast cancer cells by encapsulating them in targeted nanocapsules that will deliver the compounds directly to the cancer cells. The overall research and development goal of the project is twofold: to design and manufacture Se-nanocapsules to treat breast cancer and demonstrate their therapeutic potential in pre-clinical studies. The project is managed by the Universitat Autònoma de Barcelona (UAB) and coordinated by Professor Manuel Valiente.

To learn more about the Karolinska Institute’s innovation ecosystem for cancer startups and the implications it could have for breast cancer research, refer to the full article by Piccinetti, Santoro, and Rezk. Find it in Insights into Regional Development